Levin Capital Strategies, L.P. Inovio Pharmaceuticals, Inc. Transaction History

Levin Capital Strategies, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$2.98 - $14.09 $44,700 - $211,350	-15,000 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$1.97 - $3.72 $29,550 - $55,800	15,000 New	15,000 $49,000
Q2 2019 Aug 13, 2019	SELL	$2.29 - $4.1 $68,700 - $122,999	-30,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.34 - $5.1 $100,200 - $153,000	30,000 New	30,000 $112,000
Q4 2018 Feb 05, 2019	SELL	$3.89 - $6.11 $77,800 - $122,200	-20,000 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$3.92 - $5.58 $66,640 - $94,860	-17,000 Reduced 45.95%	20,000 $111,000
Q2 2018 Aug 07, 2018	BUY	$3.88 - $5.16 $64,020 - $85,140	16,500 Added 80.49%	37,000 $145,000
Q1 2018 May 18, 2018	BUY	$4.05 - $5.69 $83,025 - $116,645	20,500 New	20,500 $97,000
Q4 2017 Feb 09, 2018	SELL	$4.13 - $6.68 $219,303 - $354,708	-53,100 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $284,616 - $338,247	53,100	53,100 $337,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.4B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.